Neurolief, a medical technology company developing neuromodulation therapies for mental health conditions, today announced a $6 million milestone-based investment from BrainsWay Ltd., following FDA ...

Neuroscientists at University of Iowa Health Care have demonstrated for the first time that noninvasive brain stimulation can ...

In new study published in Nature Biotechnology titled, “A non-surgical brain implant enabled through cell-electronics hybrid for focal neuromodulation,” researchers from Massachusetts Institute of ...

Neuroscientists at University of Iowa Health Care have demonstrated for the first time that noninvasive brain stimulation can alter the activity of a ...

(BPT) - New precision neuromodulation techniques are redefining what's possible for neurological recovery, and the National Institutes of Health (NIH) has made a substantial investment to support the ...

Can TMS reach the hippocampus? A new study demonstrates that personalized noninvasive brain stimulation can modulate deep ...

Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature Neuroscience demonstrating that Deep Brain Stimulation (DBS) achieves therapeutic ...

Cognito Therapeutics announced today that it entered into a collaboration with Ochsner Health to advance new approaches to ...

TAMPA, Fla. & NETANYA, Israel--(BUSINESS WIRE)--Neurolief, an innovator in neurotechnology, announces the company has received Food and Drug Administration (FDA) clearance for its Relivion® system.

Scientists in Sunnybrook’s Hurvitz Brain Sciences Program recently made history as they non-invasively opened the blood-brain ...